May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Transplantation of Embryonic Stem Cells Into a Mouse Model of Retinal Degeneration
Author Affiliations & Notes
  • M.M. Lai
    Ophthalmology, Associated Retinal Consultants/William Beaumont Hospital, Royal Oak, MI
  • W.–C. Wu
    Ophthalmology, Associated Retinal Consultants/William Beaumont Hospital, Royal Oak, MI
  • S. Ohlert
    Biological Sciences, Oakland University, Rochester, MI
  • A. Vasquez
    Biological Sciences, Oakland University, Rochester, MI
  • M. Cheng
    Biological Sciences, Oakland University, Rochester, MI
  • G.R. Chaudhry
    Biological Sciences, Oakland University, Rochester, MI
  • M.T. Trese
    Ophthalmology, Associated Retinal Consultants/William Beaumont Hospital, Royal Oak, MI
  • Footnotes
    Commercial Relationships  M.M. Lai, None; W. Wu, None; S. Ohlert, None; A. Vasquez, None; M. Cheng, None; G.R. Chaudhry, None; M.T. Trese, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5737. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.M. Lai, W.–C. Wu, S. Ohlert, A. Vasquez, M. Cheng, G.R. Chaudhry, M.T. Trese; Transplantation of Embryonic Stem Cells Into a Mouse Model of Retinal Degeneration . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5737.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To examine the effects of embryonic stem cell transplantation into eyes of a mouse model of retinal degeneration

Methods: : Mouse embryonic stem cells (ESCs) labeled with the Yellow Fluorescent Protein (YFP) were grown in vitro and induced into neural progenitor cells. Eyes from mice containing the Rpe65/rd12 mutation were treated with intravitreal injections of ESCs or ESC–derived neural progenitor cells. At several time points starting at two weeks after injection, the animals were euthanized and eyes examined for presence of transplanted cells by light microscopy, fluorescent microscopy, and immunohistochemistry on both whole mount retinal preparations and retinal cross–sections. Fate and differentiation potential of the transplanted cells were also investigated by determining the expression of cell–specific genes and the YFP gene using RT–PCR.

Results: : A total of 12 eyes from mice homozygous for the Rpe65/rd12 mutation were transplanted with either undifferentiated mouse embryonic stem cells (group A) or neural progenitor cells (group B). At two weeks following transplantation, both types of transplanted cells (A and B) were present in treated eyes. Only a small percentage of transplanted cells survived the procedure. Transplanted cells were found in the vitreous, as sheets of aggregated cells along the inner retinal surface, and as individual cells within different layers of the retina. Survival, proliferation, and differentiation of transplanted cells were also examined at eight weeks and fifteen weeks following injection.

Conclusions: : Following transplantation into the vitreous cavity, ESCs and ESC–derived neural progenitor cells can survive and integrate into the retina of mice containing the Rpe65/rd12 mutation.

Keywords: transplantation • retinal degenerations: hereditary • transgenics/knock-outs 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×